emerge tirzepatide Rivals to Ozempic and Zepbound—but With a Lag Tirzepatide - CoreAge Rx

The cycling approach requires clear triggers for restarting medication

Always inform your healthcare provider about your medical history and follow their guidance to minimize this risk

The authors thank Lene Wither Takla (Novo Nordisk A/S, Global Drug Discovery, Denmark) for expert technical assistance with conducting the animal studies, Heidi Solvang Nielsen (Novo Nordisk A/S, Global Drug Discovery, Denmark) for dissection of the hippocampus for RNA-seq and histology, as well as Esther Bloem and Susanne Jrgensen for assistance with protein assays (Novo Nordisk A/S, Global Research Technologies, Denmark)

The trial compared injectable semaglutide (1.0 mg) once weekly with a placebo as an adjunct to the standard of care for the prevention of major kidney outcomes, specifically kidney failure, substantial loss of kidney function, and death from kidney or cardiovascular causes

Monitoring Report: GLP-1 RA Prescribing Trends March 2024 Data